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quantitative variables, but the highest accuracy was found with the 
SUVMAX/SUVLIVER ratio. At a cut-off of 1.5 for the SUVMAX/SU-
VLIVER ratio, the sensitivity and speciﬁcity to detect malignant LN 
invasion was 82% and 93% respectively. 
Conclusion: Integrated FDG-PET/CT has an accuracy which is too 
low to avoid invasive intrathoracic LN staging in patients with NSCLC. 
Moreover, the visual interpretation of the fusion images of the inte-
grated FDG-PET/CT can be conﬁdently replaced by the quantitative 
variable SUVMAX/SUVLIVER, without loss of accuracy for intratho-
racic LN staging. 
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Transoesophageal endoscopic ultrasound with fine needle 
aspiration(EUS-FNA) in lung cancer staging: does lymph node size 
matter? 
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Background and Objectives: Transoesophageal endoscopic ul-
trasound with real time guided ﬁne-needle aspiration (EUS-FNA) 
qualiﬁes as the staging procedure of choice to demonstrate immediate 
irresectability in patients with lung cancer presenting with enlarged 
mediastinal lymph nodes (MLN). This study compared the diagnos-
tic performance of EUS-FNA in lung cancer patients presenting with 
either enlarged or small MLN. 
Design and Patients: A prospective series in unselected lung cancer 
patients referred for EUS-FNA because of suspicion for MLN invasion 
based on the available imaging. Patients were categorized according to 
the transversal diameter of their MLN on CT-scan: group A (all MLN 
<10mm) and group B (at least 1 MLN ≥10mm). A small MLN was 
considered suspicious when either FDG-avid or when lying closely to 
the primary tumor. All patients underwent surgical-pathologic veriﬁca-
tion when EUS-FNA did not demonstrate malignant MLN invasion. 
Diagnostic performance was compared between both groups at the 
patient level (c2-test).
Results: We studied 150 consecutive lung cancer patients (121 men, 
median 65 years), with presumed malignant MLN invasion. In 108 
(72%), there was at least one enlarged MLN, while in 42 (28%), only 
small MLN were found. The sensitivity (with 95% conﬁdence interval) 
to detect malignancy was 98 (92-99)% and 92 (73-99)% for enlarged 
and small MLN, respectively (p=N.S.). The negative predictive value 
of EUS-FNA was 82 (48-97)% and 90 (66-98)% for enlarged and small 
MLN (p=N.S.). EUS-FNA prevented a surgical intervention in 90% 
and 55% of the patients with enlarged or small MLN, respectively. 
Conclusion: Lung cancer patients with suspicious MLN after imaging 
should ﬁrst be staged by EUS-FNA, regardless the size of the MLN. 
However, the moderate negative predictive value of EUS-FNA makes 
surgical-pathologic veriﬁcation still compulsory. 
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Differences in high-resolution computed tomography (HRCT) 
Findings between mucinous and non-mucinous Bronchioloalveolar 
Carcinoma (BAC) less than 3cm
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Background: Bronchioloalveolar carcinoma (BAC) histologically 
shows a unique replacing growth pattern of tumor cells along the alveo-
lar wall. In 1999, the World Health Organization (WHO) classiﬁcation 
deﬁned BAC as a form of adenocarcinoma with a pure bronchioloal-
veolar growth pattern and no evidence of stromal, vascular, or pleural 
invasion. To date, ground-glass opacity (GGO) on high-resolution com-
puted tomography (HRCT) was well known as one of the characteristic 
ﬁndings of BAC. On the other hand, although BAC is histologically 
subclassiﬁed into mucinous type and non-mucinous type, the differenc-
es in HRCT ﬁndings between two subtypes of BAC have never been 
studied. In this study, we evaluated the differences in HRCT ﬁndings 
between mucinous and non-mucinous BAC.
Methods: Forty-nine patients with BAC less than 3 cm resected be-
tween September 2002 and December 2006 at Shizuoka Cancer Center 
were included. Among 49 BACs, 33 (67%) were subclassiﬁed to non-
mucinous BAC and 16 (33%) were subclassiﬁed to mucinous BAC. 
HRCT ﬁndings in each subtype of BAC were evaluated. 
Results: Table 1 shows HRCT ﬁndings according to subtype of BAC. 
The HRCT ﬁndings included ill-deﬁned margin, consolidation,and 
pseudocavitation were seen more frequently in mucinous BAC com-
pared with non-mucinous BAC (P<0.01). Non-mucinous BAC mainly 
consisted of GGO on HRCT. In contrast, mucinous BAC mainly 
consisted of consolidation on HRCT and the ratio of GGO was less 
than 25% in all cases. Typical HRCT appearance of mucinous BAC is 
shown in Figure 1.
Conclusions: The HRCT ﬁnding of mucinous BAC was clearly dis-
tinguished from non-mucinous BAC. Our present study demonstrated 
that non-mucinous BAC showed heterogeneous HRCT appearance, but 
mucinous BAC showed homogeneous appearance that was ill-deﬁned 
subpleural consolidation with pseudocavitation or air bronchogram sur-
rounded by slight GGO. When these ﬁndings are shown on HRCT, mu-
cinous BAC should be considered as one of the differential diagnoses.
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 mucinous non-mucinous  
 No. % No. % p-value
Margin 
@Well-deﬁned 2 12.5 25 75.8  
Ill-deﬁned 14 87.5 8 24.2  
Consolidation 
+ 15 93.8 19 57.6 0.01
- 1 6.2 14 42.4  
GGO 
+ 15 93.8 33 100 -
- 1 6.2    
The ratio of GGO 
0-25% 15 93.8    
26-50% 1 6.2 3 9.1  
51-75%   6 18.2  
76-100%   24 72.7  
Air bronchogram 
+ 15 93.8 33 100  
- 1 6.2    
Pseudocavitaion 
+ 13 81.3 8 24.2  
- 3 18.7 25 75.8  
Pleural tag 
+ 3 18.7 10 30.3 0.39
- 13 81.3 23 69.7  
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The role of PET-CT results in evaluating the aggressiveness of 
small solid lung cancers
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Background: Positron emission tomography (PET) ﬁndings can be 
used to predict survival after surgical resectioning for lung cancer, as 
the results of the PET scan might be correlated with pathological ﬁnd-
ings. Although small lung cancers with ground-glass attenuation have 
a favorable prognosis, CT evaluations of tumor aggressiveness in solid 
lung cancer may be difﬁcult to carry out. Additionally, indications for 
limited resection for solid small lung cancers are controversial. This 
study was conducted to evaluate the relationship between PET-CT 
results and pathological ﬁndings in solid lung cancer cases where the 
tumors are ≤ 3 cm in size. 
Methods: From June 2004 through December 2006, 81 clinical stage 
IA patients underwent lung cancer resections. Lung nodules were clas-
siﬁed as solid or non-solid according to their CT ﬁndings. From this 
group, we reviewed the histories of 53 patients (65%) who had lung 
cancer with a solid tumor ≤ 3 cm in size, lymph node dissection and a 
preoperative PET-CT scan. Their ages ranged from 32 to 81, with an 
average of 65 years. There were 26 men and 27 women. The surgical 
procedures performed were lobectomy in 52 cases (98%) and segmen-
tectomy in 1 (2%). Patients with non-solid nodules or who underwent 
wedge resections were excluded. Four patients (8%) received adjuvant 
chemotherapy after surgery. In their pathological ﬁndings, lung cancers 
that exhibited nodal, lymphovascular or pleural invasion were deﬁned 
as invasive lung cancers. We analyzed the association between the 
pathological ﬁndings and the following preoperative clinical factors: 
age, sex, smoking history (+ or -), CEA ≤ 5.0 or > 5.0 ng/ml, tumor size 
and max SUV values. 
Results: The pathological diagnoses were as follows: 45 (85%) adeno-
carcinomas, 5 (10%) squamous cell carcinoma, 1 (2%) adenosquamous 
carcinoma, 1 (2%) atypical carcinoid, and 1 (2%) small cell carcinoma. 
There were 15 (28%) invasive lung cancer cases. Multivariate analysis 
showed tumor size (P=0.02) and max SUV (P=0.003) to be indepen-
dent predictive factors of invasive lung cancer. The proportion of 
patients with a max SUV value greater than 3.0 was signiﬁcantly higher 
in invasive lung cancer cases. When the threshold value of max SUV 
was set at 3.0, the sensitivity for predicting an invasive lung cancer in 
solid lung nodules was 93% (14/15), with a speciﬁcity of 42% (16/38). 
The positive predictive value was 39% (14/36) and the negative predic-
tive value was 94% (16/17). In the follow-up, 3 of 53 (6%) patients 
experienced a recurrence of the cancer within two years, and the preop-
erative max SUV value of all of these patients was greater than 8.0. 
Conclusions: We found that PET-CT results were correlated with 
pathological severity in small solid lung cancers. In the preoperative 
assessment, solid lung cancers with high max SUV values were recom-
mended for a standard resection.
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Endobronchial treatment in general anesthesia with jet ventilation 
is safe and useful procedure
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Background: The aim of our study is to evaluate the complications 
developing during or after the endobronchial electrosurgary and laser 
brocnhsocopy in general anesthesia with jet ventilation and investigate 
the safety of this procedures.
Methods: In this study from the years 2002-2006 158 patients under-
went 217 endobronchial therapeutic procedures. All procedures were 
performed in general anesthesia with jet ventilantion though rigid 
bronchoscope. We wedged videobronchoscop through rigid broncho-
scope. According The American Society of Anesthesiologists´(ASA) 
physical classiﬁcation were 55% patients ASA III and 45% ASA IV. 
The therapeutic endobronchial procedure was done in 129 patinets 
with endobronchial NSCLC, in 12 patients with endobronchial SCLC, 
in 6 patients with endobronchial metastases of melanoma, in 3 with 
endobronchial metastasis of renal carcinoma, in 7 patients we started 
with endobronchial treatment before the morphological diagnosis. We 
started with the endobronchiasl treatment because of dyspnea in100% 
patients (in 55% patients was dyspnea at rest), in 57 %patients was 
cough, in 12% hemoptysis, in 2% pneumonia. During and after proce-
dure we controlled oxymetry, electrocardiography, blood pressure.
